Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 25% ± 14% | |
capillary endothelial cell | 8 studies | 27% ± 9% | |
endothelial cell of artery | 6 studies | 37% ± 14% | |
enterocyte | 6 studies | 43% ± 15% |
Insufficient scRNA-seq data for expression of ACE at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 7909.01 | 577 / 578 | 97% | 11.31 | 1116 / 1155 |
prostate | 97% | 1872.17 | 237 / 245 | 97% | 7.94 | 486 / 502 |
breast | 96% | 2031.93 | 440 / 459 | 96% | 8.30 | 1071 / 1118 |
thymus | 99% | 5139.91 | 648 / 653 | 90% | 8.90 | 543 / 605 |
intestine | 85% | 6843.86 | 822 / 966 | 98% | 12.01 | 515 / 527 |
stomach | 77% | 814.58 | 277 / 359 | 99% | 13.13 | 284 / 286 |
kidney | 88% | 1380.48 | 78 / 89 | 88% | 11.31 | 797 / 901 |
esophagus | 77% | 1004.55 | 1117 / 1445 | 92% | 11.19 | 168 / 183 |
bladder | 81% | 960.71 | 17 / 21 | 83% | 6.45 | 418 / 504 |
uterus | 76% | 1289.81 | 129 / 170 | 78% | 4.86 | 358 / 459 |
pancreas | 54% | 401.38 | 178 / 328 | 99% | 11.59 | 177 / 178 |
adrenal gland | 72% | 916.37 | 185 / 258 | 79% | 31.21 | 181 / 230 |
skin | 74% | 852.57 | 1347 / 1809 | 69% | 3.80 | 324 / 472 |
ovary | 47% | 336.09 | 85 / 180 | 93% | 6.42 | 399 / 430 |
brain | 54% | 645.66 | 1419 / 2642 | 54% | 3.91 | 379 / 705 |
adipose | 99% | 2910.77 | 1186 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 6.94 | 26 / 29 |
tonsil | 0% | 0 | 0 / 0 | 87% | 4.66 | 39 / 45 |
heart | 70% | 949.10 | 606 / 861 | 0% | 0 | 0 / 0 |
spleen | 63% | 482.04 | 152 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 46% | 454.53 | 613 / 1335 | 0% | 0 | 0 / 0 |
liver | 10% | 69.32 | 22 / 226 | 36% | 2.62 | 146 / 406 |
muscle | 39% | 341.32 | 310 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.14 | 5 / 80 |
peripheral blood | 4% | 26.04 | 40 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001974 | Biological process | blood vessel remodeling |
GO_0003081 | Biological process | regulation of systemic arterial blood pressure by renin-angiotensin |
GO_0009792 | Biological process | embryo development ending in birth or egg hatching |
GO_0031100 | Biological process | animal organ regeneration |
GO_0010608 | Biological process | post-transcriptional regulation of gene expression |
GO_0060978 | Biological process | angiogenesis involved in coronary vascular morphogenesis |
GO_0071838 | Biological process | cell proliferation in bone marrow |
GO_0060218 | Biological process | hematopoietic stem cell differentiation |
GO_0002446 | Biological process | neutrophil mediated immunity |
GO_0010814 | Biological process | substance P catabolic process |
GO_0001666 | Biological process | response to hypoxia |
GO_0042755 | Biological process | eating behavior |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0042310 | Biological process | vasoconstriction |
GO_0042445 | Biological process | hormone metabolic process |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0002474 | Biological process | antigen processing and presentation of peptide antigen via MHC class I |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0008217 | Biological process | regulation of blood pressure |
GO_0001822 | Biological process | kidney development |
GO_0007565 | Biological process | female pregnancy |
GO_0042447 | Biological process | hormone catabolic process |
GO_0002003 | Biological process | angiotensin maturation |
GO_1904045 | Biological process | cellular response to aldosterone |
GO_0086091 | Biological process | regulation of heart rate by cardiac conduction |
GO_1903597 | Biological process | negative regulation of gap junction assembly |
GO_0043171 | Biological process | peptide catabolic process |
GO_0032943 | Biological process | mononuclear cell proliferation |
GO_0002019 | Biological process | regulation of renal output by angiotensin |
GO_0045907 | Biological process | positive regulation of vasoconstriction |
GO_0097746 | Biological process | blood vessel diameter maintenance |
GO_0071548 | Biological process | response to dexamethasone |
GO_0006508 | Biological process | proteolysis |
GO_0008584 | Biological process | male gonad development |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0048286 | Biological process | lung alveolus development |
GO_1902033 | Biological process | regulation of hematopoietic stem cell proliferation |
GO_0007283 | Biological process | spermatogenesis |
GO_0060177 | Biological process | regulation of angiotensin metabolic process |
GO_0010815 | Biological process | bradykinin catabolic process |
GO_0050435 | Biological process | amyloid-beta metabolic process |
GO_0019229 | Biological process | regulation of vasoconstriction |
GO_0097066 | Biological process | response to thyroid hormone |
GO_2000170 | Biological process | positive regulation of peptidyl-cysteine S-nitrosylation |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0090281 | Biological process | negative regulation of calcium ion import |
GO_0014910 | Biological process | regulation of smooth muscle cell migration |
GO_0031667 | Biological process | response to nutrient levels |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0003084 | Biological process | positive regulation of systemic arterial blood pressure |
GO_0060047 | Biological process | heart contraction |
GO_0038166 | Biological process | angiotensin-activated signaling pathway |
GO_0034616 | Biological process | response to laminar fluid shear stress |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0005768 | Cellular component | endosome |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0097225 | Cellular component | sperm midpiece |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005764 | Cellular component | lysosome |
GO_0031526 | Cellular component | brush border membrane |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004175 | Molecular function | endopeptidase activity |
GO_1901363 | Molecular function | heterocyclic compound binding |
GO_0070573 | Molecular function | metallodipeptidase activity |
GO_0031711 | Molecular function | bradykinin receptor binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0008238 | Molecular function | exopeptidase activity |
GO_0008241 | Molecular function | peptidyl-dipeptidase activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0031434 | Molecular function | mitogen-activated protein kinase kinase binding |
GO_0031404 | Molecular function | chloride ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0004180 | Molecular function | carboxypeptidase activity |
GO_0008240 | Molecular function | tripeptidyl-peptidase activity |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0051019 | Molecular function | mitogen-activated protein kinase binding |
Gene name | ACE |
Protein name | Angiotensin converting enzyme Angiotensin I converting enzyme Angiotensin-converting enzyme (EC 3.4.-.-) Angiotensin-converting enzyme (ACE) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form] Angiotensin-converting enzyme (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) |
Synonyms | DCP DCP1 |
Description | FUNCTION: Dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of a variety of circulating hormones, such as angiotensin I, bradykinin or enkephalins, thereby playing a key role in the regulation of blood pressure, electrolyte homeostasis or synaptic plasticity . Composed of two similar catalytic domains, each possessing a functional active site, with different selectivity for substrates . Plays a major role in the angiotensin-renin system that regulates blood pressure and sodium retention by the kidney by converting angiotensin I to angiotensin II, resulting in an increase of the vasoconstrictor activity of angiotensin . Also able to inactivate bradykinin, a potent vasodilator, and therefore enhance the blood pressure response . Acts as a regulator of synaptic transmission by mediating cleavage of neuropeptide hormones, such as substance P, neurotensin or enkephalins . Catalyzes degradation of different enkephalin neuropeptides (Met-enkephalin, Leu-enkephalin, Met-enkephalin-Arg-Phe and possibly Met-enkephalin-Arg-Gly-Leu) . Acts as a regulator of synaptic plasticity in the nucleus accumbens of the brain by mediating cleavage of Met-enkephalin-Arg-Phe, a strong ligand of Mu-type opioid receptor OPRM1, into Met-enkephalin (By similarity). Met-enkephalin-Arg-Phe cleavage by ACE decreases activation of OPRM1, leading to long-term synaptic potentiation of glutamate release (By similarity). Also acts as a regulator of hematopoietic stem cell differentiation by mediating degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) . Acts as a regulator of cannabinoid signaling pathway by mediating degradation of hemopressin, an antagonist peptide of the cannabinoid receptor CNR1 . Involved in amyloid-beta metabolism by catalyzing degradation of Amyloid-beta protein 40 and Amyloid-beta protein 42 peptides, thereby preventing plaque formation . Catalyzes cleavage of cholecystokinin (maturation of Cholecystokinin-8 and Cholecystokinin-5) and Gonadoliberin-1 (both maturation and degradation) hormones . Degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) and amyloid-beta proteins is mediated by the N-terminal catalytic domain, while angiotensin I and cholecystokinin cleavage is mediated by the C-terminal catalytic region . .; FUNCTION: [Angiotensin-converting enzyme, soluble form]: Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region. .; FUNCTION: [Isoform Testis-specific]: Isoform produced by alternative promoter usage that is specifically expressed in spermatocytes and adult testis, and which is required for male fertility . In contrast to somatic isoforms, only contains one catalytic domain . Acts as a dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of substrates . The identity of substrates that are needed for male fertility is unknown (By similarity). May also have a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. The GPIase activity was reported to be essential for the egg-binding ability of the sperm (By similarity). This activity is however unclear and has been challenged by other groups, suggesting that it may be indirect (By similarity). . FUNCTION: Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region. . FUNCTION: Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region. . FUNCTION: Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region. . FUNCTION: Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region. . |
Accessions | ENST00000578839.5 J3QSC7 Q1KSD9 A0A0A0MSN4 J3KTB8 ENST00000582627.1 ENST00000290863.10 [P12821-3] J3KRH5 ENST00000582761.1 ENST00000290866.10 [P12821-1] ENST00000579204.1 ENST00000579314.5 J3QLR4 I6L9B3 Q1KSG0 P12821 Q3KRI5 X4Y8J8 J3KSQ5 ENST00000582005.5 J3KTH9 Q3KRI4 ENST00000413513.7 [P12821-4] I3UJJ7 ENST00000582678.5 J3KS28 ENST00000579726.5 ENST00000428043.5 |